These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The development of bleomycin-induced pulmonary fibrosis in neutrophil-depleted and complement-depleted rats. Thrall RS; Phan SH; McCormick JR; Ward PA Am J Pathol; 1981 Oct; 105(1):76-81. PubMed ID: 6170232 [TBL] [Abstract][Full Text] [Related]
7. Bleomycin-induced pulmonary fibrosis in rats: biochemical demonstration of increased rate of collagen synthesis. Phan SH; Thrall RS; Ward PA Am Rev Respir Dis; 1980 Mar; 121(3):501-6. PubMed ID: 6158281 [TBL] [Abstract][Full Text] [Related]
8. Rapamycin attenuates bleomycin-induced pulmonary fibrosis in rats and the expression of metalloproteinase-9 and tissue inhibitors of metalloproteinase-1 in lung tissue. Jin X; Dai H; Ding K; Xu X; Pang B; Wang C Chin Med J (Engl); 2014; 127(7):1304-9. PubMed ID: 24709185 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of l-mimosine on bleomycin-induced pulmonary fibrosis in rats: Role of eIF3a and p27. Li XW; Hu CP; Li YJ; Gao YX; Wang XM; Yang JR Int Immunopharmacol; 2015 Jul; 27(1):53-64. PubMed ID: 25957199 [TBL] [Abstract][Full Text] [Related]
10. Rat lung fibroblast collagen metabolism in bleomycin-induced pulmonary fibrosis. Phan SH; Varani J; Smith D J Clin Invest; 1985 Jul; 76(1):241-7. PubMed ID: 2410457 [TBL] [Abstract][Full Text] [Related]
11. Diallylsulfide attenuates excessive collagen production and apoptosis in a rat model of bleomycin induced pulmonary fibrosis through the involvement of protease activated receptor-2. Kalayarasan S; Sriram N; Soumyakrishnan S; Sudhandiran G Toxicol Appl Pharmacol; 2013 Sep; 271(2):184-95. PubMed ID: 23656969 [TBL] [Abstract][Full Text] [Related]
12. Biosynthesis of interstitial and basement membrane collagens in pulmonary fibrosis. Quinones F; Crouch E Am Rev Respir Dis; 1986 Dec; 134(6):1163-71. PubMed ID: 2431638 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of antifibrotic drugs in bleomycin-induced pulmonary fibrosis in hamsters. Zuckerman JE; Hollinger MA; Giri SN J Pharmacol Exp Ther; 1980 Jun; 213(3):425-31. PubMed ID: 6162945 [TBL] [Abstract][Full Text] [Related]
14. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Zhang HY; Gharaee-Kermani M; Zhang K; Karmiol S; Phan SH Am J Pathol; 1996 Feb; 148(2):527-37. PubMed ID: 8579115 [TBL] [Abstract][Full Text] [Related]
15. Reduction in pulmonary fibrosis in vivo by halofuginone. Nagler A; Firman N; Feferman R; Cotev S; Pines M; Shoshan S Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1082-6. PubMed ID: 8887611 [TBL] [Abstract][Full Text] [Related]
16. Losartan attenuates bleomycin-induced pulmonary fibrosis in rats. Yao HW; Zhu JP; Zhao MH; Lu Y Respiration; 2006; 73(2):236-42. PubMed ID: 16330873 [TBL] [Abstract][Full Text] [Related]
17. Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat model. Hart DA; Whidden P; Green F; Henkin J; Woods DE Clin Invest Med; 1994 Apr; 17(2):69-76. PubMed ID: 7516275 [TBL] [Abstract][Full Text] [Related]
18. Effect of leukotriene receptor antagonists on lung fibrosis in rats. Shaker OG; Sourour DA J Appl Toxicol; 2011 Oct; 31(7):678-84. PubMed ID: 21381050 [TBL] [Abstract][Full Text] [Related]
19. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. Keane MP; Belperio JA; Moore TA; Moore BB; Arenberg DA; Smith RE; Burdick MD; Kunkel SL; Strieter RM J Immunol; 1999 May; 162(9):5511-8. PubMed ID: 10228032 [TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats. Li S; Yang X; Li W; Li J; Su X; Chen L; Yan G Respiration; 2012; 84(6):509-17. PubMed ID: 23006535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]